Cefteram pivoxil
CAS No. 82547-81-7
Cefteram pivoxil( Ro 19-5248 | T-2588 )
Catalog No. M27537 CAS No. 82547-81-7
Cefteram pivoxil (CFTM-PI) is an oral antibiotic available in powder suspension and tablet formulations indicated in China for the treatment of bacterial infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | Get Quote |
|
| 5MG | 70 | Get Quote |
|
| 10MG | 115 | Get Quote |
|
| 25MG | 206 | Get Quote |
|
| 50MG | 311 | Get Quote |
|
| 100MG | 464 | Get Quote |
|
| 200MG | 698 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCefteram pivoxil
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefteram pivoxil (CFTM-PI) is an oral antibiotic available in powder suspension and tablet formulations indicated in China for the treatment of bacterial infections.
-
DescriptionCefteram pivoxil (CFTM-PI) is an oral antibiotic available in powder suspension and tablet formulations indicated in China for the treatment of bacterial infections.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 19-5248 | T-2588
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorPAFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82547-81-7
-
Formula Weight593.63
-
Molecular FormulaC22H27N9O7S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCO\N=C(\C(=O)N[C@H]1[C@H]2SCC(Cn3nnc(C)n3)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dupont L, Germain G, Dideberg O. Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. Pharmacol Res Commun. 1986 Aug;18 Suppl:25-32.
molnova catalog
related products
-
BAL30072
BAL30072 is a monocyclic beta-lactam antibiotic that shows potent activity against MDR Pseudomonas aeruginosa and Acinetobacter sp.
-
Gatifloxacin
A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
-
Norlichexanthone
Norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases such as type 2 diabetes, metabolic syndrome, atherosclerosis and cardiovascular disease.
Cart
sales@molnova.com